Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jürgen Dinger

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Fortschritte Der Neurologie-Psychiatrie|November 6, 2025
[Wilson's disease - interdisciplinary networking, better treatment]Ulrike Reuner, Jürgen Dinger
The Journal of Family Planning and Reproductive Health Care|January 14, 2010
Risk of venous thromboembolism among users of oral contraceptives: a review of two recently published studiesSamuel Shapiro, Jürgen Dinger
Resuscitation Plus|July 15, 2024
The side-entry method: An easy approach of umbilical vascular catheterizationMario Rüdiger, Jürgen Dinger
Obstetrics and Gynecology|October 3, 2013
Cardiovascular risk associated with the use of an etonogestrel-containing vaginal ringJürgen Dinger, Sabine Möhner, Klaas Heinemann
Obstetrics and Gynecology|August 25, 2009
Rate of pregnancy after using drospirenone and other progestin-containing oral contraceptivesMaureen Cronin, Ilka Schellschmidt, Jürgen Dinger
Drug Safety|October 9, 2004
Safety of a new oral contraceptive containing drospirenoneLothar A J Heinemann, Jürgen Dinger
Contraception|January 31, 2016
Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptivesJürgen Dinger, Sabine Möhner, Klaas Heinemann
Contraception|March 1, 2014
Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral ContraceptivesJürgen Dinger, Kristina Bardenheuer, Klaas Heinemann
Contraception|June 26, 2016
Impact of estrogen type on cardiovascular safety of combined oral contraceptivesJürgen Dinger, Thai Do Minh, Klaas Heinemann
Contraception|February 12, 2011
Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancerJürgen Dinger, Kristina Bardenheuer, Thai Do Minh
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Fortschritte Der Neurologie-Psychiatrie|November 6, 2025
[Wilson's disease - interdisciplinary networking, better treatment]Ulrike Reuner, Jürgen Dinger
The Journal of Family Planning and Reproductive Health Care|January 14, 2010
Risk of venous thromboembolism among users of oral contraceptives: a review of two recently published studiesSamuel Shapiro, Jürgen Dinger
Resuscitation Plus|July 15, 2024
The side-entry method: An easy approach of umbilical vascular catheterizationMario Rüdiger, Jürgen Dinger
Obstetrics and Gynecology|October 3, 2013
Cardiovascular risk associated with the use of an etonogestrel-containing vaginal ringJürgen Dinger, Sabine Möhner, Klaas Heinemann
Obstetrics and Gynecology|August 25, 2009
Rate of pregnancy after using drospirenone and other progestin-containing oral contraceptivesMaureen Cronin, Ilka Schellschmidt, Jürgen Dinger
Drug Safety|October 9, 2004
Safety of a new oral contraceptive containing drospirenoneLothar A J Heinemann, Jürgen Dinger
Contraception|January 31, 2016
Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptivesJürgen Dinger, Sabine Möhner, Klaas Heinemann
Contraception|March 1, 2014
Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral ContraceptivesJürgen Dinger, Kristina Bardenheuer, Klaas Heinemann
Contraception|June 26, 2016
Impact of estrogen type on cardiovascular safety of combined oral contraceptivesJürgen Dinger, Thai Do Minh, Klaas Heinemann
Contraception|February 12, 2011
Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancerJürgen Dinger, Kristina Bardenheuer, Thai Do Minh
Pageof 3